Ryu J-H, Koo T Y, Ha J Y, Jung M R, Ha J W, Yang J
Transplant Center, Seoul National University Hospital, Seoul, Republic of Korea.
Transplant Center, Seoul National University Hospital, Seoul, Republic of Korea; Department of Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
Transplant Proc. 2018 May;50(4):1041-1044. doi: 10.1016/j.transproceed.2018.02.038.
Although a nationwide activation system has been developed to increase deceased donor kidney transplantation (DDKT), there is still enormous discrepancy between transplant need and deceased donor supply in Korea, and therefore waiting time to DDKT is still long. We need to determine the current status of waiting time and the risk factors for long waiting time. We retrospectively analyzed the medical records of the patients on the wait list for DDKT at the Seoul National University Hospital from 2000 to 2017. Among 2,211 wait-listed patients, 606 (27.5%) received DDKT and mean waiting time to DDKT was 45 months. Among them, blood type A was most prevalent (35.6%) and type AB was the least (14.0%). Panel-reactive assay (PRA) was positive in 59 (11.0%) in the first transplant group and 25 (35.0%) in retransplant group. Waiting time in PRA-positive recipients was 63 and 66 months in the first transplant group and retransplant group, respectively. However, waiting time for patients with negative PRA was 42.8 months. Waiting time was shorter in blood type AB (39 months) than other types (46 months). Waiting time was the shortest in children and adolescents. Among patients who were still on the wait list, retransplantation candidates, especially with PRA higher than 50%, had longer waiting time than first transplant candidates. In conclusion, non-AB blood type, positive PRA, and adult age were significantly associated with long waiting time. Therefore, it is necessary to establish a management strategy such as tailored desensitization for highly sensitized patients on the wait list to reduce their waiting time.
尽管韩国已建立了全国性的激活系统以增加死体供肾移植(DDKT),但移植需求与死体供者供应之间仍存在巨大差距,因此等待 DDKT 的时间仍然很长。我们需要确定等待时间的现状以及等待时间过长的风险因素。我们回顾性分析了 2000 年至 2017 年首尔国立大学医院等待 DDKT 的患者的病历。在 2211 名等待名单上的患者中,606 名(27.5%)接受了 DDKT,DDKT 的平均等待时间为 45 个月。其中,A型血最为常见(35.6%),AB 型血最少(14.0%)。在首次移植组中,群体反应性抗体检测(PRA)阳性的患者有 59 名(11.0%),再次移植组中有 25 名(35.0%)。PRA 阳性受者在首次移植组和再次移植组中的等待时间分别为 63 个月和 66 个月。然而,PRA 阴性患者的等待时间为 42.8 个月。AB 型血患者的等待时间(39 个月)比其他血型患者(46 个月)短。儿童和青少年的等待时间最短。在仍在等待名单上的患者中,再次移植候选者,尤其是 PRA 高于 50%的患者,等待时间比首次移植候选者更长。总之,非 AB 血型、PRA 阳性和成年与等待时间过长显著相关。因此,有必要制定管理策略,如为等待名单上的高敏患者量身定制脱敏方案,以缩短他们的等待时间。